| ImmuneSupport.com |
|
|
|||||||||||||||||||||||||||||||||
|
CFIDS and Anesthesia: What are the risks?By Elisabeth A. Crean Anecdotes have piled up over the years about the especially difficult time persons with CFIDS (PWCs) have recovering from anesthesia. PWCs are hypersensitive to many medications, including anesthetics, often tolerating just a fraction of the standard dosage levels. The reactions some patients experience may be a sign that their immune and endocrine systems don't respond normally to pharmaceutical challenges and stimuli. Unfortunately, no rigorous scientific studies have been published on any of these issues. Meanwhile, every day PWCs are facing the imminent possibility of surgery, and need to educate their doctors now. What the doctors say In contrast, Dr. Class notes, "There is a commonly used group of anesthetics, known as histamine-releasers, which are probably best avoided by CFIDS patients." This group includes the thiobarbituates, such as sodium pentathol, probably the most common induction agent and a known histamine-releaser. "In addition, there is a broad group of muscle relaxants in the Curare family, namely Curare, Tracrium, and Mevacurium, which are also potent histamine-releasers and should be avoided by CFIDS patients." Because many histamine-releasing agents are commonly used during emergency surgery, Dr. Class advises PWCs: "Wear a medical alert bracelet in the event you are unconscious. I would mention on the bracelet that you cannot receive any histamine-releasing drugs." Other options for communicating this information include carrying instructions in your wallet, educating your family and insisting that it be included in your medical chart. CFIDS can be an indication that certain organs, like the liver, may already be overtaxed, and processes like cell metabolism disturbed. An anesthesia plan must take this into account. Dr. Cheney advises against using anesthetic gases like Halothane that can potentially be toxic to the liver. "Patients with CFIDS are known to have reactivated herpes group viruses, which can produce mild and usually subclinical hepatitis. Hepatotoxic anesthetic gases may provoke fulminate (sudden, severe onset) of hepatitis." Dr. Cheney also notes that electron beam x-ray spectroscopy techniques have shown that PWCs do not have enough magnesium and potassium in their cells, which can be problematic. The magnesium and potassium depletion can result in cardiac arrhythmias during anesthesia. "For this reason, I would recommend the patient be given Micro-K using lOmEq tablets, 1 tablet BID and magnesium sulfate 50% solution, 2cc IM 24 hours to surgery." As technological advances like laproscopy make surgery less invasive, surgeons can perform more procedures where they combine a local anesthetic with a sedative instead of using general anesthesia. But even local anesthetics used outside of surgery should be approached with caution when being administered to PWCs. "Lidocaine should be used sparingly and without epinephrine," Dr. Cheney says. In an article for the February CFIDS Support Network update, Dr. Charles Lapp of North Carolina also emphasizes checking serum magnesium and potassium before surgery and replenishing these minerals if the levels are borderline or low. Seriously ill patients, or those frequently on steroid therapy, might need pre-operative cortisol testing and supplementation as well. According to Dr. Lapp, doctors may also have to modify pre- and post-operative sedation. "Most CFIDS patients are also extremely sensitive to sedative medications, including benzodiazepines, antihistamines and psychotropics-which should be used sparingly and in small doses until the patient's response can be assessed." The consequences of neurally mediated hypotension (NMH)-frequently seen in CFIDS patients concern Lapp as well. These include low plasma volume, low red blood cell mass, venous pooling and vasovagal syncope (fainting). "Syncope may be precipitated by catecholamines (epinephrine), sympathomimetics (isoproterenol) and vasodilators (nitric oxide, nitroglycerin, beta-blockers and hypotensive agents)," Dr. Lapp says. "Care should be taken to hydrate patients prior to surgery and to avoid drugs that stimulate neurogenic syncope or lower blood pressure." The need for extra hydration might mean checking into the hospital the day before surgery-as was customary in pre-managed care times-instead of just a few hours before. Almost everyone feels weak and tired after an operation. But people with CFIDS should prepare to experience increased fatigue and problems with memory and concentration for a much longer period than normal, says Dr. Charles Shepherd of Gloucestershire, England, in his book Living with ME. He speculates that reduced blood flow to the brain during surgery and the immediate post-operative recovery period may partially explain this. Other possible culprits may be specific anes-thesias, particularly those used to correct a low heart rate or reverse muscle paralysis, which can further disturb brain chemistry already altered by CFIDS. Dr. Shepherd suggests referring surgeons and anesthesiologists to a research paper about acetylcholine levels in PWCs (such as Chadhuri, A., et al, Chronic fatigue syndrome: a disorder of central cholinergic transmission, Journal of Chronic Fatigue Syndrome, 1997; 3: 3-16). This may be a good way to alert them to possible complications with your recovery. How you can prepare
Source: Reprinted with permission from The CFIDS Chronicle, Vol. 13, Winter 2000, pp 11-13. |